02/12/2026
Two NREF grant recipients, Drs. Adam Sonabend (2012–13) and Mark Youngblood (2022–23), are among the authors of a newly published study highlighting a non-invasive method to predict chemotherapy response in glioblastoma.
Published in Nature Communications, the research examines how advanced imaging and molecular analysis may help physicians better determine which patients are most likely to benefit from chemotherapy. This work represents an important step toward more personalized and effective care for patients facing one of the most aggressive brain tumors.
Read the full article: https://ow.ly/myjV50YexVY
In his NREF testimonial, Dr. Youngblood discusses the findings from his fellowship research project, shares the current status of that work and explains how NREF support helped shape his goals as a neurosurgeon-scientist.
Watch Dr. Youngblood’s testimonial: https://ow.ly/lQKJ50Yexy5
Support the future of neurosurgical research: https://ow.ly/Iwx850YexEZ